A Map of Alzheimer's Disease–Signaling Pathways: A Hope for Drug Target Discovery

E-ISSN： 1532-6535|93|5|399-401

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.5, 2013-05, pp. : 399-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR Signaling and Drug Discovery

Oncology, Vol. 77, Iss. 6, 2010-02 ,pp. : 400-410

Karger

Access to resources Recommend Favorite

Cutting-edge Patents in Alzheimer's Disease Drug Discovery: Anticipation of Potential Future Treatments

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 113-123

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E receptor pathways in Alzheimer disease

WILEY INTERDISCIPLINARY REVIEWS: SYSTEMS BIOLOGY AND MEDICINE (ELECTRONIC), Vol. 6, Iss. 3, 2014-05 ,pp. : 255-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alzheimer''s disease therapy: a moving target

By Castellani Rudy J Zhu Xiongwei Perry George

Therapy, Vol. 8, Iss. 5, 2011-09 ,pp. : 457-458

Future Medicine

Access to resources Recommend Favorite

Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions

Current Signal Transduction Therapy, Vol. 6, Iss. 3, 2011-09 ,pp. : 428-440

Bentham Science Publishers

Access to resources Recommend Favorite